The U.S. Food and Drug Administration has approved Guidant Corp.'s Vitality HE implantable cardioverter defibrillator. The new device, which is used to shock an irregular heartbeat back to normal, will be available in the United States in October.
http://c.moreover.com/click/here.pl?r399834153
http://c.moreover.com/click/here.pl?r399834153